SEC 13F Intelligence

Elk Creek Partners, LLC / KPTIEUR

Elk Creek Partners, LLC’s Karyopharm Therapeutics Inc Position

Does Elk Creek Partners, LLC own Karyopharm Therapeutics Inc (KPTIEUR)? Yes700.0K shares worth $13M (+2.31% of its 13F portfolio) as of Q1 2020, up from 460.3K shares the prior filed quarter.

Position Value
$13M
Q1 2020
Shares
700.0K
% of Portfolio
+2.31%
Quarters Held
3
currently held

Position History KPTIEUR

Reported value by quarter
Q3 ’19: $12MQ3 ’19Q4 ’19: $9MQ4 ’19Q1 ’20: $13MQ1 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2020700.0K$13M+2.31%
Q4 2019460.3K$9M+1.01%
Q3 20191.27M$12M+1.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Elk Creek Partners, LLC’s full portfolio or all institutional holders of KPTIEUR.